Interim Data from IMAGE-BTK Clinical Trial Presented at AMP 2022

Author's Avatar
Sep 01, 2022

REDWOOD CITY, CA / ACCESSWIRE / September 1, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced the presentation of interim data from the IMAGE-BTK clinical study for Pantheris SV at the annual AMP (Amputation Prevention Symposium) conference in August.